Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
HUMAN PHARMA from Charleroi, company number BE0800381939, closed financial year 2025 with a result of € 46,829 after tax. For that financial year HUMAN PHARMA recorded a gross margin of € 114,557 and equity of € 224,840. Compared with financial year 2024, the result moved from € 84,759 to € 46,829. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 224,840
▲ 26% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 46,829
▼ 45% vs 2024
Profit after tax over the fiscal year.
€ 7,833
▼ 48% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 221,840.
People and assets in 2025
0.8
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 32,965
▲ 9% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 6,024
▼ 11% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 14,441
▼ 73% vs 2024
€ 10,400 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 78,016
▼ 57% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,723
▼ 43% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 167,788 | € 161,960 | € 114,557 | ▼ 29% |
| Profit after taxes | € 90,252 | € 84,759 | € 46,829 | ▼ 45% |
| Equity | € 93,252 | € 178,011 | € 224,840 | ▲ 26% |
| Total debts | € 106,599 | € 351,374 | € 209,292 | ▼ 40% |
| Cash | € 16,325 | € 15,020 | € 7,833 | ▼ 48% |
| Retained profit | € 90,252 | € 175,011 | € 221,840 | ▲ 27% |
| Bank debt | € 0 | € 52,945 | € 14,441 | ▼ 73% |
| Balance sheet total | € 208,851 | € 538,385 | € 434,132 | ▼ 19% |
| Employees (FTE) | 36,816.1 | 0.7 | 0.8 | ▲ 0.1 |
Key figures of HUMAN PHARMA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HUMAN PHARMA?
What happened at HUMAN PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 46,829 (▼ 45% vs 2024). filed late Source: NBB ↗
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
- SERGE AIME NGANDEU NGONLEBEK became a director. NBB
In short
From € 90,252 profit in 2023 to € 46,829 profit in 2025.
Paid € 64,039 in corporate taxes since 2023.
Best year ever: 2023, with € 90,252 profit.
On average € 0 of value added per employee in 2023.
A new publication or filing at HUMAN PHARMA? We notify you, reason included.
Follow HUMAN PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind HUMAN PHARMA is SERGE AIME NGANDEU NGONLEBEK.
Directors
According to the 2025 annual accounts
SERGE AIME NGANDEU NGONLEBEK
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Rue du Sanatorium 36
6001 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0800.381.939
- VAT number
- BE 0800.381.939
- Registered office
- Rue du Sanatorium 36, 6001 Charleroi
- Names & denominations
- HUMAN PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2023
- Peppol
- Active · Active since 17 Mar 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Vervaardiging van farmaceutische grondstoffen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels